Log in to save to my catalogue

A homozygous stop-gain variant in ARHGAP42 is associated with childhood interstitial lung disease, s...

A homozygous stop-gain variant in ARHGAP42 is associated with childhood interstitial lung disease, s...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2561940643

A homozygous stop-gain variant in ARHGAP42 is associated with childhood interstitial lung disease, systemic hypertension, and immunological findings

About this item

Full title

A homozygous stop-gain variant in ARHGAP42 is associated with childhood interstitial lung disease, systemic hypertension, and immunological findings

Publisher

United States: Public Library of Science

Journal title

PLoS genetics, 2021-07, Vol.17 (7), p.e1009639-e1009639

Language

English

Formats

Publication information

Publisher

United States: Public Library of Science

More information

Scope and Contents

Contents

ARHGAP42
encodes Rho GTPase activating protein 42 that belongs to a member of the GTPase Regulator Associated with Focal Adhesion Kinase (GRAF) family. ARHGAP42 is involved in blood pressure control by regulating vascular tone. Despite these findings, disorders of human variants in the coding part of
ARHGAP42
have not been reported. Here,...

Alternative Titles

Full title

A homozygous stop-gain variant in ARHGAP42 is associated with childhood interstitial lung disease, systemic hypertension, and immunological findings

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_plos_journals_2561940643

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2561940643

Other Identifiers

ISSN

1553-7404,1553-7390

E-ISSN

1553-7404

DOI

10.1371/journal.pgen.1009639

How to access this item